LEONARD E. POST - 17 Mar 2025 Form 4 Insider Report for CG Oncology, Inc. (CGON)

Role
Director
Signature
/s/ Joshua F. Patterson, Attorney-in-Fact for Leonard Post
Issuer symbol
CGON
Transactions as of
17 Mar 2025
Net transactions value
-$27,400
Form type
4
Filing time
18 Mar 2025, 16:30:26 UTC
Previous filing
19 Feb 2025
Next filing
29 Apr 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CGON Common Stock Options Exercise $600 +1,000 $0.6000 1,000 17 Mar 2025 Direct
transaction CGON Common Stock Sale $28,000 -1,000 -100% $28.00 0 17 Mar 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CGON Director Stock Option (right to buy) Options Exercise $0 -1,000 -0.76% $0.000000 130,077 17 Mar 2025 Common Stock 1,000 $0.6000 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 6, 2024.
F2 Fully vested